EUCR
Eucrates Biomedical Acquisition Corp. Ordinary Shares
EUCR
EUCR
Delisted
EUCR was delisted on the 26th of April, 2023.
37 hedge funds and large institutions have $76.1M invested in Eucrates Biomedical Acquisition Corp. Ordinary Shares in 2022 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 12 increasing their positions, 4 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
37
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$2.56M | |
| 2 | +$1.73M | |
| 3 | +$1.6M | |
| 4 |
PAMP
Polar Asset Management Partners
Toronto,
Ontario, Canada
|
+$1.58M |
| 5 |
SC
Sculptor Capital
New York
|
+$784K |
Top Sellers
| 1 | -$4.92M | |
| 2 | -$1.4M | |
| 3 | -$740K | |
| 4 |
ICMH
Integrity Capital Management (HK)
Central,
Hong Kong
|
-$96K |
| 5 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
-$51K |